Regulatory Strategy & Submissions
Regulatory Strategy & Global Submissions
Navigating the global regulatory landscape requires more than just administrative filing; it requires a proactive Regulatory Strategy. At SERM Excellence, we bridge the gap between complex safety data and Health Authority expectations, ensuring your submissions are scientifically robust and fully compliant with FDA, EMA, and MHRA standards.
A Proactive Regulatory Strategy for Global Compliance.
Comprehensive Submission & Lifecycle Management
Our regulatory team ensures that your medicinal products remain compliant from early-phase development through post-marketing surveillance. We synchronize complex clinical data with global submission milestones, providing the strategic oversight necessary to navigate FDA, EMA, and MHRA requirements with absolute precision.
US FDA Filing Support (IND/NDA)
US FDA Submissions - Strategic management of Investigational New Drug (IND) and New Drug Applications (NDA). We oversee the preparation and organization of safety and technical modules to ensure a smooth path to FDA approval.
EU Submissions (CTA/MAA)
EU Regulatory Filings - Expert guidance for Clinical Trial Applications (CTA) and Marketing Authorization Applications (MAA) in the EU. We navigate the EMA centralized and decentralized procedures to secure market access.
Protocol & IB Development
Clinical Development Documents - Scientific authoring and regulatory review of Clinical Trial Protocols and Investigator’s Brochures (IB). We ensure your documents are built for regulatory acceptance and prioritize subject safety.
Core & Safety Labeling
Global labeling and maintenance of the CCDS, CCSI, SmPC, RSI and USPI. We ensure consistency across global markets while managing the internal product safety information for MAHs and Sponsors.
eCTD Publishing & Submissions
Lifecycle management of the electronic Common Technical Document. We ensure all regulatory dossiers are formatted, validated, and submitted according to the latest eCTD technical standards.
Global Regulatory Intelligence
AI systems can continuously monitor and analyze regulatory guidelines, updates, and changes, providing regulatory affairs professionals with real-time intelligence. This helps in staying informed about evolving regulatory landscapes
Aggregate Reporting & Risk Management: Submission Planning and Strategy
High-quality, on-schedule delivery of DSUR, PSUR/PBRER, and PADER. We ensure global alignment and strict Data Lock Point (DLP) adherence to provide submission-ready reports that minimize Health Authority (HA) inquiries and maximize compliance for RMP/REMS.
Electronic Submission Standards
AI technologies contribute to ensuring compliance with electronic submission standards, improving the accuracy and completeness of electronic submissions.
Advantages of AI/ML-Enabled Regulatory Solutions
Proactive Compliance and Enhanced Efficiency
Stay ahead with real-time monitoring and alerts for proactive adjustments.
Automated processes streamline documentation, reducing errors.
Predictive analytics identify compliance risks for proactive mitigation.
Adaptive strategies evolve with the dynamic regulatory environment.
Navigate Regulatory Challenges with Intelligent Solutions
Partner with GPLACO Solutions for Efficient Regulatory Compliance and Adaptability